We are live on
!
Find out more
PVWM
Point View Wealth Management Portfolio holdings
AUM
$246M
1-Year Est. Return
10.77%
This Fund
S&P 500
This Quarter
Est. Return
+3.98%
1 Year Est. Return
+10.77%
3 Year Est. Return
+27.03%
5 Year Est. Return
+74.48%
10 Year Est. Return
–
AUM
$208M
AUM Growth
+$5.15M
(+2.5%)
Cap. Flow
-$2.07M
Cap. Flow
% of AUM
-0.99%
Top 10 Holdings %
Top 10 Hldgs %
15.14%
Holding
275
New
15
Increased
71
Reduced
139
Closed
9
Avg Time Held
10.3
quarters
Top 10 Avg Time Held
9.7
quarters
Top 20 Avg Time Held
9.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baker Hughes
BKR
|
+$1.12M |
| 2 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$562K |
| 3 |
Kroger
KR
|
+$399K |
| 4 |
Johnson Controls International
JCI
|
+$313K |
| 5 |
IGR
CBRE Global Real Estate Income Fund
IGR
|
+$275K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHI
Baker Hughes
BHI
|
+$1.23M |
| 2 |
MetLife
MET
|
+$397K |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$312K |
| 4 |
Procter & Gamble
PG
|
+$303K |
| 5 |
Microsoft
MSFT
|
+$283K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 14.59% |
| 2 | Technology | 12.22% |
| 3 | Financials | 11.7% |
| 4 | Healthcare | 10.61% |
| 5 | Energy | 10.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CBI
101
DELISTED
Chicago Bridge & Iron Nv
CBI
| $735K | 0.35% |
43,697
+5,426
| +14% | +$83.1K |
2014 Q4
11 quarters
|
|
102
Bausch Health
BHC
$2.22B
| $734K | 0.35% |
51,188
-4,355
| -8% | -$65.9K |
2016 Q2
5 quarters
|
|
103
Apple
AAPL
$4.98T
| $732K | 0.35% |
18,976
-712
| -4% | -$27.6K |
2016 Q4
3 quarters
|
|
104
Ingredion
INGR
$6.07B
| $732K | 0.35% |
6,060
-1,125
| -16% | -$137K |
2013 Q4
15 quarters
|
|
105
Diageo
DEO
$49.3B
| $730K | 0.35% |
5,518
-190
| -3% | -$24.6K |
2015 Q3
8 quarters
|
|
106
Williams-Sonoma
WSM
$28.1B
| $702K | 0.34% |
28,126
+7,494
| +36% | +$174K |
2016 Q3
4 quarters
|
|
107
Best Buy
BBY
$18.2B
| $694K | 0.33% |
12,174
-1,094
| -8% | -$62.7K |
2013 Q4
15 quarters
|
|
108
DELISTED
CSRA Inc.
CSRA
| $690K | 0.33% |
21,357
-1,006
| -4% | -$32.4K |
2015 Q4
7 quarters
|
|
109
AstraZeneca
AZN
$246B
| $689K | 0.33% |
10,168
+1,299
| +15% | +$82.1K |
2013 Q4
15 quarters
|
|
110
Arrow Electronics
ARW
$11.5B
| $685K | 0.33% |
8,508
+154
| +2% | +$12.2K |
2013 Q4
15 quarters
|
|
111
Aberdeen Multi-Market Income Fund
MMT
$231M
| $677K | 0.33% |
108,379
+3,205
| +3% | +$19.9K |
2014 Q1
14 quarters
|
|
112
Kirby Corp
KEX
$7.17B
| $667K | 0.32% |
10,113
| – | – |
2016 Q1
6 quarters
|
|
113
DELISTED
COMPANHIA VALE DO RIO DOCE ADS(REP 1 COM SH)
RIO
| $663K | 0.32% |
65,753
-4,849
| -7% | -$48.9K |
2014 Q1
14 quarters
|
|
114
Baxter International
BAX
$12.8B
| $649K | 0.31% |
10,330
| – | – |
2015 Q4
7 quarters
|
|
115
CSX Corp
CSX
$88.5B
| $642K | 0.31% |
35,490
-2,817
| -7% | -$48.3K |
2013 Q4
15 quarters
|
|
116
Las Vegas Sands
LVS
$23.4B
| $641K | 0.31% |
9,986
-318
| -3% | -$19.7K |
2016 Q1
6 quarters
|
|
117
Occidental Petroleum
OXY
$61.1B
| $622K | 0.3% |
9,686
+3,167
| +49% | +$193K |
2015 Q4
7 quarters
|
|
118
Royce Micro-Cap Trust
RMT
$717M
| $622K | 0.3% |
66,227
-742
| -1% | -$6.42K |
2013 Q4
15 quarters
|
|
119
Ford
F
$47.9B
| $621K | 0.3% |
51,829
-3,267
| -6% | -$36.8K |
2013 Q4
15 quarters
|
|
120
BlackRock Multi-Sector Income Trust
BIT
$641M
| $619K | 0.3% |
33,061
| – | – |
2016 Q4
3 quarters
|
|
121
Ralph Lauren
RL
$22.2B
| $615K | 0.3% |
6,959
+229
| +3% | +$18.9K |
2015 Q3
8 quarters
|
|
122
Herbalife
HLF
$1.43B
| $614K | 0.29% |
18,076
-1,802
| -9% | -$61.7K |
2014 Q2
13 quarters
|
|
123
TotalEnergies
TTE
$195B
| $596K | 0.29% |
11,123
+551
| +5% | +$28.3K |
2013 Q4
15 quarters
|
|
|
AGU
124
DELISTED
Agrium
AGU
| $594K | 0.29% |
5,535
-275
| -5% | -$27.4K |
2013 Q4
15 quarters
|
|
125
WPP
WPP
$5.36B
| $584K | 0.28% |
6,292
+814
| +15% | +$79.8K |
2013 Q4
15 quarters
|
|
Similar funds
EA
CCM
JCM
BG
MCFIG
BRC
TFM
RCA
Point View Wealth Management's Q3 2017 Portfolio in Review
As of Q3 2017, Point View Wealth Management held 275 positions worth $208M, up 2.5% from $203M the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Point View Wealth Management's Q3 2017 filing shows 15 new, 71 increased, 139 reduced and 9 closed positions. Its largest new stake was Baker Hughes: 31,448 shares worth $1.15M. The largest sale was Baker Hughes, an estimated $1.23M.
By sector, the portfolio is most concentrated in Miscellaneous at 15% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
- Point View Wealth Management's largest Q3 2017 buy was Baker Hughes: 31,448 shares worth $1.15M.
- Point View Wealth Management added most to Teva Pharmaceutical Industries Limited in Q3 2017, an estimated $562K increase.
- Point View Wealth Management's biggest Q3 2017 reduction was MetLife, cutting an estimated $397K.
- Point View Wealth Management fully exited Baker Hughes in Q3 2017, selling an estimated $1.23M.
- Point View Wealth Management's ten largest holdings make up 15% of its $208M portfolio in Q3 2017.
- Point View Wealth Management opened 15 new positions and closed 9 in Q3 2017.
- Point View Wealth Management's portfolio value rose 2.5% quarter-over-quarter to $208M.
Based on Point View Wealth Management's 13F filing for Q3 2017, filed 8 Nov 2017.